Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
NCT00073515 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 115
Last updated 2010-02-03
Summary
This trial is for patients with a central venous catheter (a vascular access device) that is not functioning properly (unable to withdraw blood). The trial compares a new blood clot dissolving agent (alfimeprase) against the currently used treatment.
Conditions
- Catheters, Indwelling
Interventions
- DRUG
-
Alfimeprase
Sponsors & Collaborators
-
ARCA Biopharma, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
ThrombX Retriever for Acute Ischemic Stroke Trial
NCT05270122 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention
NCT05931887 ·Status: COMPLETED ·Phase: NA
-
Crux Biomedical Vena Cava Filter Study - United States
NCT01120509 ·Status: COMPLETED ·Phase: PHASE3
-
The AbsorbaSeal Vascular Closure Device Trial
NCT03730571 ·Status: TERMINATED ·Phase: NA
-
Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4
NCT01120535 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure
NCT02438475 ·Status: COMPLETED ·Phase: PHASE4
-
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)
NCT07219758 ·Status: RECRUITING ·Phase: NA
-
Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 ("RETRIEVE 3")
NCT01120522 ·Status: COMPLETED ·Phase: PHASE3
-
AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
NCT04635501 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients
NCT04689451 ·Status: UNKNOWN
-
Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study
NCT03019302 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study Evaluating Use of the CapBuster Medical Device System for the Crossing of Chronic Total Occlusions
NCT04710342 ·Status: UNKNOWN ·Phase: NA
-
ALN OATF Vena Cava Filter
NCT05785676 ·Status: COMPLETED
-
Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients
NCT01343680 ·Status: TERMINATED ·Phase: PHASE3
-
Contact Activation of Coagulation in Newly Inserted Central Venous Catheters
NCT07014722 ·Status: RECRUITING ·Phase: NA
-
Cyanoacrylate Closure for Treatment of Venous Leg Ulcers
NCT04011371 ·Status: COMPLETED ·Phase: NA
-
Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization
NCT03182530 ·Status: UNKNOWN ·Phase: NA
-
Femoral Artery Crossover Rates in 1000 Consecutive Radial Cath Labs Procedures.
NCT02711514 ·Status: TERMINATED
-
Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease
NCT07012551 ·Status: NOT_YET_RECRUITING
-
ArterX Surgical Sealant, A Randomized Prospective Multicenter Trial
NCT00759681 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure
NCT05468957 ·Status: WITHDRAWN ·Phase: NA
-
Risk Factors for Thrombosis in Children With Central Venous Lines
NCT04117217 ·Status: COMPLETED
-
Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)
NCT01460966 ·Status: COMPLETED ·Phase: NA
-
Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System
NCT01121510 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Assess Veinplicity Venous Access Device Safety and Effectiveness
NCT03109405 ·Status: COMPLETED ·Phase: NA